Profile
SSKN ABT BSX-PA SYK BSX MDT
Company Name STRATA Skin Sciences, Inc. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Boston Scientific Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $5.80M $233.52B $175.45B $150.29B $145.95B $121.32B
Employees 0.11K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Dolev Rafaeli Robert B. Ford Michael F. Mahoney Kevin A. Lobo Michael F. Mahoney Geoffrey Straub Martha
Ratings
SSKN ABT BSX-PA SYK BSX MDT
Quant Rating Score 1 4 3 3 3
Quant Rating Strong Sell Buy Neutral Neutral Neutral
Trading
SSKN ABT BSX-PA SYK BSX MDT
Last Close $1.39 $134.17 $122.18 $376.88 $98.5 $94.58
High 52 $3.35 $140.22 $122.18 $403.53 $108.14 $94.58
Low 52 $1.39 $111.1 $122.18 $337.28 $82.57 $79.61
Price vs. 52 Week High -58.51 % -4.31 % 0 % -6.6 % -8.91 % 0 %
Price vs. 52 Week Low 0 % 20.77 % 0 % 11.74 % 19.29 % 18.8 %
Total Return
SSKN ABT BSX-PA SYK BSX MDT
1 Month Return -22.35 % 2.99 % 0 % -1.29 % -4.42 % 1.91 %
3 Month Return -41.1 % 1.33 % 0 % 0.97 % -2.83 % 10.32 %
6 Month Return -48.52 % 6.23 % 0 % 0.24 % -0.73 % 2.57 %
9 Month Return -53.67 % 19.87 % 0 % 4.93 % 11.89 % 18.18 %
YTD Return -52.23 % 18.62 % 0 % 4.67 % 10.28 % 18.4 %
1 Year Return -53.51 % 16.79 % 0 % 4.29 % 19.29 % 7.32 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SSKN ABT BSX-PA SYK BSX MDT
Dividend Yield Percentage (TTM) - 1.73 % - 0.84 % - 2.97 %
Dividend Paid and Capex Coverage Ration (TTM) -2.97 % 1.45 % 4.3 % 2.39 % 4.3 % 1.31 %
Dividend Per Share (TTM) - 2.32 % - 3.32 % - 2.81 %
Payout Ratio (TTM) - 28.42 % 0.92 % 42.87 % 0.92 % 77.26 %
Growth
SSKN ABT BSX-PA SYK BSX MDT
Asset Growth -13.94 % 11.2 % 12.12 % 12.12 % 1.89 %
Gross Profit Growth 3.36 % 6.43 % 16.26 % 16.26 % 3.58 %
Revenue Growth 0.61 % 4.59 % 17.61 % 17.61 % 3.62 %
Revenue 3 Year 0.13 % -0.18 % 36.16 % 36.16 % 10.52 %
Revenue 5 Year -10.74 % 34.24 % 47.52 % 47.52 % 20.96 %
Revenue 10 Year -89.8 % 80.43 % 104.22 % 104.22 % 41.05 %
EBIT Growth 12.21 % 3.45 % 18.25 % 18.25 % 14.42 %
Net Income Growth 6.87 % 134.18 % 16.38 % 16.38 % 26.82 %
Net Income 3 Yeari Growth Per Share -233.36 % 94.27 % 72.31 % 72.31 % -3.39 %
Net Income 5 Yeari Growth Per Share -123.56 % 271.11 % -62.7 % -62.7 % 1.52 %
Net Income 10 Yeari Growth Per Share 99.82 % 410.99 % 1502.13 % 1502.13 % 48.51 %
Operating Income Growth -7.57 % 6.46 % 20.82 % 20.82 % 15.77 %
Operating Cash Flow Growth (CFG) 136.22 % 17.86 % 37.24 % 37.24 % 3.79 %
Operating 3 Year CFG -88.85 % -16.72 % 77.55 % 77.55 % 0.13 %
Operating 5 Year CFG -92.91 % 42.4 % 76.92 % 76.92 % 1.55 %
Operating 10 Year CFG 100 % 102.79 % 143.61 % 143.61 % 22.45 %
EPS Growth 16.13 % 134.55 % 16.55 % 16.55 % 31.05 %
EPS Diluted Growth 16.13 % 133.64 % 16.25 % 16.25 % 30.8 %
Book Value Per Share -64.06 % 23.54 % 11.25 % 11.25 % -1.16 %
Share Holder 3 Year Equity Growth Per Share -82.5 % 36.46 % 26.58 % 26.58 % -4.58 %
Share Holder 5 Year Equity Growth Per Share -85.42 % 56.53 % 48.35 % 48.35 % -1.29 %
Share Holder 10 Year Equity Growth Per Share -99.89 % 92.83 % 186.31 % 186.31 % -23.12 %
Dividend Per Share Growth - 8.02 % -100 % -100 % 1.11 %
Dividend 3 Year Growth Per Share - 22.8 % -100 % -100 % 10.78 %
Dividend 5 Year Growth Per Share - 72.53 % - - 29.33 %
Dividend 10 Year Growth Per Share - 148.92 % - - 128.74 %
Debt Growth 5.16 % -3.77 % 17.44 % 17.44 % 13.95 %
Free Cash Flow Growth 73.85 % 25.54 % 55.31 % 55.31 % -0.29 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 25 Apr 2025
Profitability
SSKN ABT BSX-PA SYK BSX MDT
Gross Profit Margin TTM 57.89 % 52.79 % 63.23 % 62.19 % 63.23 % 63.44 %
Return on Assets TTM -37.56 % 16.64 % 6.02 % 6.3 % 6.02 % 5.12 %
Return on Equity TTM -266.94 % 29.93 % 11.49 % 14.08 % 11.49 % 9.62 %
Return on Capital Employed TTM -60.53 % 10.7 % 8.53 % 13.86 % 8.53 % 7.71 %
Net Income Per EBT TTM 98.55 % 176.99 % 83.43 % 87.08 % 83.43 % 82.32 %
EBT Per Ebit TTM 115.72 % 104.64 % 96.68 % 61.93 % 96.68 % 92.49 %
EBIT Per Revenue TTM -30.81 % 17.51 % 16.77 % 22.72 % 16.77 % 17.9 %
Cash Flow To Debt Ratio TTM -192.98 % 67.25 % 35.63 % 27.83 % 35.63 % 24.98 %
Receivables Turnover TTM 8.17 4.21 6.57 6.08 6.57 5.46
Payables Turnover TTM 4.7 4.73 7.07 6.25 7.07 4.89
Inventory Turnover TTM 4.27 2.93 2.38 1.7 2.38 -33.52
Fixed Asset Turnover TTM 338.78 % 378.32 % 467.97 % 560.03 % 467.97 % -6785.71 %
Asset Turnover TTM 106.92 % 51.32 % 44.5 % 51.41 % 44.5 % 37.59 %
Operating Cash Flow Per Share TTM -0.05 5.19 2.9 12.47 2.9 5.58
Free Cash Flow Per Share TTM -0.07 3.89 2.24 10.53 2.24 4.14
Cash Per Share TTM 14.3 % 418.4 % 36.12 % 644.69 % 36.12 % 633.66 %
Operating Cash Flow Sales Ratio TTM -6.36 % 20.96 % 23.17 % 20.01 % 23.17 % 20.89 %
Free Cash Flow Operating Cash Flow Ratio TTM 133.68 % 74.97 % 77.27 % 84.43 % 77.27 % 74.21 %
Cash Flow Coverage Ratios TTM -192.98 % 67.25 % 35.63 % 27.83 % 35.63 % 24.98 %
Price To Free Cash Flows Ratio TTM -2.08 34.47 44.3 37.35 44.08 22.88
Price To Operating Cash Flows Ratio TTM -27.74 25.84 34.15 31.52 33.99 16.96
Price Cash Flow Ratio TTM -27.74 25.84 34.15 31.52 33.99 16.96
Income Statement (TTM)
SSKN ABT BSX-PA SYK BSX MDT
Revenue $0.03B $41.95B $16.75B $22.6B $16.75B $33.54B
Gross Profit $0.02B $21.33B $10.27B $13.98B $10.27B $21.91B
Gross Profit Ratio 56.85% 50.83% 61.31% 61.87% 61.31% 65.32%
EBITDA $-0B $10.83B $3.94B $4.94B $3.94B $9.22B
Net Income $-0.01B $13.4B $1.85B $2.99B $1.85B $4.66B
EPS Diluted -0.26 7.64 1.25 7.76 1.25 3.61
Balance Sheet (MRQ)
SSKN ABT BSX-PA SYK BSX MDT
Long Term Debt $0.02B $13.52B $9.37B $12.57B $9.37B $25.64B
Total Liabilities $0.03B $33.51B $17.39B $22.34B $17.39B $43.42B
Total Equity $0B $47.9B $22B $20.63B $22B $48.26B
Total Investments $0B $1.24B $0.56B $0.88B $0.56B $6.75B
Total Debt $0.02B $15.28B $11.15B $14.12B $11.15B $28.52B
Total Assets $0.04B $81.41B $39.4B $42.97B $39.4B $91.68B
Cash Flow Statement (TTM)
SSKN ABT BSX-PA SYK BSX MDT
Net Income $-0.01B $13.4B $1.85B $2.99B $1.85B $4.69B
Inventory $0B $-0.06B $-0.23B $-0.21B $-0.23B $-0.29B
Dividends Paid $0B $-3.84B $0B $-1.22B $0B $-3.59B
Operating Cash Flow $0B $8.56B $3.44B $4.24B $3.44B $7.04B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.76B $-0.79B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 134.56
ADGM Adagio Medical Holdings, Inc. 1.8
AEMD Aethlon Medical, Inc. 0.78
AFIB Acutus Medical, Inc. 0.0004
AHCO AdaptHealth Corp. 9.225
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 132.55
ALUR Allurion Technologies Inc. 2.06
AMIX Autonomix Medical, Inc. Common Stock 1.041
ANIK Anika Therapeutics, Inc. 8.93
AORT Artivion, Inc. 41.38
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 2.23
ARAY Accuray Incorporated 1.735
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 15.21
AVNS Avanos Medical, Inc. 12.28
AVR Anteris Technologies Global Corp. Common Stock 5.39
AXDX Accelerate Diagnostics, Inc. 0.034
ETFs With Exposure to SSKN
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 327.17
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 144.84
VXF Vanguard Extended Market Index Fund 0.00005 213
IWC iShares Micro-Cap ETF 0.0003 150.9
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00001 110.6
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 110.58
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 52.41
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 52.4
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.4
VTSAX Vanguard Total Stock Market Index Fund 0 158.29
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00005 158.73
VITSX Vanguard Total Stock Market Index Fund 0 158.32
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00005 158.74
DFQTX DFA U.S. Core Equity 2 Portfolio 0 42.94
VTS.AX Vanguard US Total Market Shares Index ETF 0 493.31
VEMPX Vanguard Extended Market Index InstlPlus 0.00005 391.73
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 296.99
Unlock